Home » Stocks » NRXP

NRx Pharmaceuticals, Inc. (NRXP)

Stock Price: $14.86 USD -0.92 (-5.83%)
Updated Jun 18, 2021 4:00 PM EDT - Market closed
After-hours: $14.90 +0.04 (0.27%) Jun 18, 7:39 PM
Market Cap 780.79M
Revenue (ttm) n/a
Net Income (ttm) -77.54M
Shares Out 11.28M
EPS (ttm) -7.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 18
Last Price $14.86
Previous Close $15.78
Change ($) -0.92
Change (%) -5.83%
Day's Open 15.53
Day's Range 14.77 - 15.75
Day's Volume 389,249
52-Week Range 10.50 - 76.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced positive data from its Zyesami (Aviptadil) Expanded Access Protocol (EAP) in patients with critical COVID-19 and respiratory failure. Overall, patien...

4 days ago - Benzinga

RADNOR, Pa., June 15, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), a clinical stage pharmaceutical company, today announced positive data from its ZYESAMI™ (Aviptadil) Expanded Access Protoc...

4 days ago - PRNewsWire

NRx Pharmaceuticals (NASDAQ: NRXP) has applied with FDA requesting Emergency Use Authorization (EUA) for Zyesami (Aviptadil-acetate) for critically ill COVID-19 patients suffering from respiratory failu...

2 weeks ago - Benzinga

RADNOR, Pa., June 1, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP) (NRx), a clinical stage pharmaceutical company, today announced it has filed an application with U.S. Food and Drug Administr...

2 weeks ago - PRNewsWire

RADNOR, Pa., May 27, 2021 /PRNewswire/ -- Today, NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced the election of The Honorable Herbert Raymond "H.R.

3 weeks ago - PRNewsWire

RADNOR, Pa., May 26, 2021 /PRNewswire/ -- Today, NRx Pharmaceuticals, Inc., (Nasdaq:NRXP) (NRx) through its Georgia subsidiary,  announced that it has signed a master services agreement with Cromos Phar...

3 weeks ago - PRNewsWire

RADNOR, Pa., May 25, 2021 /PRNewswire/ -- Today, NeuroRx, Inc., announced it has been approved by the Nasdaq for listing on the Nasdaq Global Market, following the completion of its business combination...

Other stocks mentioned: BRPA
3 weeks ago - PRNewsWire

Big Rock Partners Recommends All Stockholders Vote "FOR" ALL Proposals at Annual Meeting NEW YORK, NY / ACCESSWIRE / May 21, 2021 / Big Rock Partners Acquisition Corp. ("Big Rock" or "BRPA") (Nasdaq:BRP...

Other stocks mentioned: BRPA
4 weeks ago - Accesswire

RADNOR, Pa. and TBLISI, Georgia, April 28, 2021 /PRNewswire/ -- NeuroRx today announces that it has met with Dr. Ekaterine Tikaradze, Minister of Health of Georgia, and other senior leadership, to immed...

Other stocks mentioned: BRPA
1 month ago - PRNewsWire

Big Rock Partners Acquisition Corp (NASDAQ: BRPA) shares are trading higher after the company's SPAC merger target, NeuroRx, on Monday confirmed dosing of the first patient in a Phase 3 trial of ZYESAMI...

Other stocks mentioned: BRPA
1 month ago - Benzinga

RADNOR, Pa., April 26, 2021 /PRNewswire/ -- Dosing of the first patient in a phase 3 clinical trial of ZYESAMI (aviptadil acetate) was announced by the National Institutes of Health (NIH) last week.

Other stocks mentioned: BRPA
1 month ago - PRNewsWire

RADNOR, Pa., April 19, 2021 /PRNewswire/ -- The issues raised by Relief Therapeutics in its release dated April 19, 2021 have no bearing on NeuroRx's ability or commitment to deliver a safe, effective, ...

Other stocks mentioned: BRPA
2 months ago - PRNewsWire

NEW YORK, NY / ACCESSWIRE / April 7, 2021 / Big Rock Partners Acquisition Corp. (Nasdaq:BRPA) ("Big Rock") today clarified the procedure for stockholder redemptions in connection with Big Rock's special...

Other stocks mentioned: BRPA
2 months ago - Accesswire

Good morning and welcome to the stock market today! The Ever Given is free, Wall Street is caught up in a fire sale tizzy and cryptos are climbing again.

Other stocks mentioned: BRPA, CS, RLFTF
2 months ago - InvestorPlace

After taking a hit in recent weeks, RLFTF stock investors got some good news on its respiratory failure treatment collaboration with BRPA target NeuroRx. The post RLFTF Stock: Why Relief Therapeutics an...

Other stocks mentioned: RLFTF, BRPA
2 months ago - InvestorPlace

RADNOR, Pa., March 29, 2021 /PRNewswire/ -- NeuroRx, Inc. today reports 60-day results of the Phase 2b/3 trial of intravenously-administered ZYESAMI™ (aviptadil acetate) for the treatment of respiratory...

Other stocks mentioned: BRPA
2 months ago - PRNewsWire

RADNOR, Pa., March 26, 2021 /PRNewswire/ -- NeuroRx, Inc. announces completion of top line data analysis of the 60-day results in its phase 2b/3 clinical trial, conducted under FDA Fast Track Designatio...

Other stocks mentioned: BRPA
2 months ago - PRNewsWire

WILMINGTON, DE and DELRAY BEACH, FL / ACCESSWIRE / March 15, 2021 / NeuroRx, Inc. ("NeuroRx"), a clinical stage-small molecule pharmaceutical company and Big Rock Partners Acquisition Corp. ("Big Rock")...

Other stocks mentioned: BRPA
3 months ago - Accesswire

NEW YORK, March 12, 2021 /PRNewswire/ --                                         If you own shares in any of the companies listed above and                             would like to discuss our investig...

Other stocks mentioned: ALXN, BRPA, KTYB
3 months ago - PRNewsWire

NEW YORK, Feb. 26, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or...

Other stocks mentioned: ALXN, BRPA, STPK
3 months ago - PRNewsWire

RADNOR, Pa., Feb. 23, 2021 /PRNewswire/ -- NeuroRx, Inc. announced today that the Phase 2b/3 trial* of ZYESAMI™ (aviptadil, previously RLF-100™) for the treatment of Respiratory Failure in critically il...

Other stocks mentioned: BRPA
3 months ago - PRNewsWire

NEW YORK, Feb. 7, 2021 /PRNewswire/ -- Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the ...

Other stocks mentioned: BRPA
4 months ago - PRNewsWire

It may be a short week with Christmas just around the corner but that doesn't mean there's a lack of SPAC merger news to discuss. The post Top SPAC Merger News This Week: Porch.com, Butterfly Network, O...

Other stocks mentioned: OUST, PTAC, BRPA, CLA, LGVW
5 months ago - InvestorPlace

BRPA stock is shooting higher as investors process news that Big Rock Partners will take NeuroRx public. Here's what to know.

Other stocks mentioned: BRPA
5 months ago - InvestorPlace

NEW YORK, Dec. 15, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Big Rock Partners Acquisition Corp. ("B...

Other stocks mentioned: BRPA
6 months ago - PRNewsWire

About NRXP

NRx Pharmaceuticals, Inc. a clinical-stage, small molecule pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.

Industry
Biotechnology
Founded
2015
Stock Exchange
NASDAQ
Ticker Symbol
NRXP
Full Company Profile

Financial Performance

Financial Statements